Sculptra in Singapore: how PLLA builds collagen, and what to weigh first

The basics

What Sculptra is, and what poly-L-lactic acid does

Sculptra is a brand of injectable poly-L-lactic acid (PLLA), a synthetic polymer that the body breaks down slowly into lactic acid. The same family of material has long been used in dissolving stitches. For facial treatment it comes as a freeze-dried powder, 150 mg of PLLA microparticles per vial with sodium carboxymethylcellulose and mannitol, which the doctor mixes with sterile water before use. It was approved in Europe in 1999 and in the United States in 2004.

It is not a gel filler in the usual sense. A hyaluronic acid (HA) filler occupies space and changes shape on the day. PLLA microparticles instead set off a controlled tissue response in which your own cells lay down new collagen around them, so the result is built gradually by your body rather than by the product itself.

In Singapore, the Health Sciences Authority (HSA) classes all dermal fillers as Class D medical devices, its highest risk class. PLLA is injected by a doctor after a consultation, and it is sensible to ask which product is being used and to keep a record of the amount and areas treated.

Mechanism

How collagen builds over the months after treatment

On the day, the treated area looks fuller, but much of that is the mixing water. It is absorbed within a few days and the early fullness goes, which surprises some people. The particles that remain prompt immune cells and fibroblasts to gather and lay down collagen as the PLLA slowly breaks down.

Human tissue studies support this. In a study of 14 adults who had skin biopsies after PLLA injection, type I collagen increased significantly at three and six months, with no or only mild inflammation. That timing is why results are judged over months, not days.

A 2026 randomised trial in China gives a useful comparison. In 252 people treated for nasolabial folds with either a PLLA product or HA filler, HA did better at week 4, reflecting its immediate effect, while PLLA did better from week 36 onwards. The PLLA group needed more early sessions. Results vary from person to person, and the change is usually described as gradual rather than dramatic.

Preparation

Dilution, mixing and the number of sessions

How PLLA is mixed affects both the result and the risk of lumps. For years the powder was mixed hours or days ahead and left to stand; older practice often used about 5 mL of water per vial. A 2020 laboratory study found that mixing a vial with 8 mL of sterile water and shaking it vigorously for one minute gave the same physical properties as the standard standing time, with optional lidocaine for comfort, and since 2021 the manufacturer has allowed use immediately after mixing.

The doctor adjusts the dilution and depth to the area: more dilute and spread evenly where broad support is needed, placed deep over bone or in the deeper fat for volume. Thicker, more concentrated mixes and shallow placement are linked to more lumps, which is one reason technique matters as much as the product.

PLLA is given as a course rather than in one visit. In the main nasolabial fold trial, people had one to four sessions three weeks apart, and many plans use sessions about four to six weeks apart. The spacing lets the doctor see how your collagen has responded before deciding whether more is needed. The number of sessions is set at consultation, not fixed in advance.

Main risk

Nodules: why they happen and how the risk is reduced

Small bumps (papules) and firmer lumps (nodules) are the side effect particularly characteristic of PLLA. A review of technique linked them to incorrect mixing, an uneven suspension, injecting too superficially and, at the time, skipping massage afterwards. Placement near the mouth and eyes, where muscles move a lot and the skin is thin, carries more risk.

In a survey of 221 patients at one London clinic, 41 reported papules or nodules one to six months after treatment. The majority were barely noticeable and settled on their own, but 12 had obvious nodules, nine of them around the mouth; five resolved without treatment and seven were treated, five with steroid injections and two with surgery. The authors advised avoiding those areas. That clinic mixed each vial with 5 mL of water, less than many doctors use now.

With more dilute mixing, the picture looks better. In a small randomised trial of 20 people whose vials were mixed with 8 mL in total, no nodules appeared in either group over six months, whether or not people massaged afterwards using the traditional '5-5-5' routine. The numbers are small, so doctors still give individual aftercare advice. Late, inflamed lumps appearing many months later are rarer and should be assessed by a doctor.

Overfill

Overfill and 'pillow face': why PLLA is different from HA

The overfilled, puffy look often called pillow face usually comes from HA filler. HA binds water and lasts longer than many people expect: in an MRI study of 33 people, gel was still present in all of them at least two years after mid-face filler, and in one person up to 15 years later. Repeated top-ups can stack layer on layer, but HA can be dissolved with hyaluronidase.

PLLA behaves differently. The early swelling from the mixing water fades within days, so PLLA is less likely to look heavy straight after treatment. The risk of too much comes later and more slowly: from adding sessions before earlier ones have matured, using a large total amount in one area, or placing product where volume was never lost. What builds up then is your own collagen and fibrous tissue around the particles, not a gel.

That is why a cautious plan with PLLA aims slightly under, then reviews. If you already have a lot of earlier filler, it usually makes sense to find out what is there before adding any collagen stimulator on top.

No dissolving

It cannot be dissolved: options if there is a lump or too much

Hyaluronidase, the enzyme used to dissolve filler, works only on hyaluronic acid. It does not break down PLLA, and there is no equivalent enzyme for collagen stimulators. This is the single biggest practical difference between Sculptra and HA filler, and it is why conservative dosing comes first.

If a problem does occur, the approach depends on what it is. Many small papules settle with time. Persistent nodules may be treated with injections of saline or a steroid into the lump, and a discrete lump that does not respond may need surgical removal, which is a reason to involve a plastic surgeon in some cases. Ultrasound helps show where the material sits before anything is done.

On drsinyong.com, Dr Sin Yong describes mapping over-stimulated tissue with ultrasound and then using the Sculpting mode of his Time Freeze Laser LCLR® protocol to take away the excess, including migrated PLLA. This is his clinical protocol rather than something tested in published trials, it can remove more fat in a zone than intended, and it is not suitable for lean faces where removing tissue would not help; suitability is decided at assessment.

Suitability

Who PLLA tends to suit, and who it does not

PLLA suits gradual, broad change in people who can wait and return for a course. It is a poor fit for anyone who needs a visible result by a fixed date.

If hollowing has appeared quickly, you have lost weight without trying, or one side has changed much more than the other, see a doctor about the cause before any cosmetic treatment.

• Often suitable: hollow temples, flattened mid-cheeks, a gaunt look after weight loss, early loss of support along the jawline, and thin skin that needs more substance.
• Often not suitable: the lips, superficial placement around the eyes, and anyone wanting a precise, same-day change such as a chin or nose shape.
• Not advised: pregnancy or breastfeeding, active skin infection or inflammation in the area, or allergy to any component.
• Discuss first: autoimmune disease, keloid scarring, blood thinners or bleeding problems, recent dental infection, and any earlier filler or non-absorbable implant in the same area.
• Heavy sagging with excess skin is better discussed in terms of lifting or surgery, and a plastic surgeon's opinion may be more useful than any injectable.

Alternatives

Alternatives to weigh before choosing PLLA

HA filler gives a precise change the same day and can be dissolved, which suits structural shaping and anyone who wants to see a small step before committing. Polycaprolactone (PCL) biostimulators give some immediate shape from their gel carrier before a slower collagen effect. Poly-D,L-lactic acid (PDLLA) products are often placed more superficially for skin quality.

If your main concern is crepey or dehydrated skin rather than lost volume, a skin booster or bio-remodelling HA injection may fit better. If it is laxity, energy-based lifting such as HIFU or radiofrequency may be considered. Doing nothing, or waiting, is also a valid choice, and it is one Dr Sin Yong always includes.

Safety

Aftercare, and warning signs that need help at once

Bruising, tenderness and swelling at the injection points usually settle within about a week. You may be asked to massage the area for a few days, avoid strenuous exercise, saunas and facial treatments for a short time, and attend a review before the next session. Photographs taken in the same light help, because gradual change is easy to forget.

Any injection into the face can, rarely, block a blood vessel. Biostimulators are not exempt: in 2023 HSA reported Singapore's first case of blindness after a dermal filler, involving a PDLLA product, and found no product quality problem. Seek help immediately if, after any injection, skin near the area turns pale, white, blotchy or dusky, pain keeps increasing, or your vision changes. Contact the treating clinic at once or go to an emergency department.

At SkinRev Lab

Sculptra in Singapore: what happens at SkinRev Lab

PLLA and PCL collagen biostimulators are performed by Dr Sin Yong after a consultation at SkinRev Lab, #B1-28 CityLink Mall, 1 Raffles Link, linked underground to City Hall and Esplanade MRT, open daily 11am to 8pm (WhatsApp +65 8266 9585), or at IN Eternity Clinic, 9 Scotts Road, #12-01 Pacific Plaza, beside Orchard MRT, Monday to Saturday 11am to 8pm (WhatsApp SkinRev Lab on +65 8266 9585 or IN Eternity Clinic on +65 8815 3008).

He takes a history of earlier treatments, examines bone, fat and skin at rest and in motion, and where earlier filler is involved he can scan it with ultrasound before adding anything. He then explains the options, which can include PLLA, another biostimulator, HA filler, lifting, a skin-quality treatment or no treatment at all. Treatment is priced at consultation, with the whole plan explained before you start. Our pages do not commit to a brand, so ask which product would be used and why.

Sources

References & sources

1. Vasconcelos-Berg R, Real J, Wenz F, Avelar LET. Safety of the immediate reconstitution of poly-l-lactic acid for facial and body treatment: a multicenter retrospective study. J Cosmet Dermatol. 2024;23(12):3918-3923. PMID 39285829.
2. Baumann K, Alm J, Norberg M, Ejehorn M. Immediate use after reconstitution of a biostimulatory poly-L-lactic acid injectable implant. J Drugs Dermatol. 2020;19(12):1199-1203. PMID 33346524.
3. Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-922. PMID 23464798.
4. Wang Z, Ting W, Zhao H, et al. Long-term correction of nasolabial folds using poly-L-lactic acid microspheres: a multicenter, double-blinded, randomized trial. Aesthet Surg J Open Forum. 2026;8:ojag001. PMID 41694326.
5. Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448-462. PMID 20159311.
6. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg. 2009;35(Suppl 1):344-349. PMID 19207324.
7. Wu DC, Goldman MP. The efficacy of massage in reducing nodule formation after poly-L-lactic acid administration for facial volume loss: a randomized, evaluator-blinded clinical trial. Dermatol Surg. 2016;42(11):1266-1272. PMID 27618389.
8. Health Sciences Authority, Singapore. HSA concludes its investigation into AestheFill. 12 October 2023.

Common questions

Your questions,
answered